711 related articles for article (PubMed ID: 20520592)
1. A novel STAT3 inhibitor, S3I-201, attenuates renal interstitial fibroblast activation and interstitial fibrosis in obstructive nephropathy.
Pang M; Ma L; Gong R; Tolbert E; Mao H; Ponnusamy M; Chin YE; Yan H; Dworkin LD; Zhuang S
Kidney Int; 2010 Aug; 78(3):257-68. PubMed ID: 20520592
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cells protect against obstruction-induced renal fibrosis by decreasing STAT3 activation and STAT3-dependent MMP-9 production.
Matsui F; Babitz SK; Rhee A; Hile KL; Zhang H; Meldrum KK
Am J Physiol Renal Physiol; 2017 Jan; 312(1):F25-F32. PubMed ID: 27760767
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel attenuates renal interstitial fibroblast activation and interstitial fibrosis by inhibiting STAT3 signaling.
Zhang L; Xu X; Yang R; Chen J; Wang S; Yang J; Xiang X; He Z; Zhao Y; Dong Z; Zhang D
Drug Des Devel Ther; 2015; 9():2139-48. PubMed ID: 25931810
[TBL] [Abstract][Full Text] [Related]
4. Heat Shock Protein 72 Antagonizes STAT3 Signaling to Inhibit Fibroblast Accumulation in Renal Fibrogenesis.
Zhou Y; Cao S; Li H; Peng X; Wang Y; Fan J; Wang Y; Zhuang S; Yu X; Mao H
Am J Pathol; 2016 Apr; 186(4):816-28. PubMed ID: 26851345
[TBL] [Abstract][Full Text] [Related]
5. Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis.
Yan Y; Ma L; Zhou X; Ponnusamy M; Tang J; Zhuang MA; Tolbert E; Bayliss G; Bai J; Zhuang S
Kidney Int; 2016 Jan; 89(1):68-81. PubMed ID: 26444028
[TBL] [Abstract][Full Text] [Related]
6. S3I-201 ameliorates tubulointerstitial lesion of the kidneys in MRL/lpr mice.
Du Y; Zhang W; Liu S; Feng X; Gao F; Liu Q
Biochem Biophys Res Commun; 2018 Sep; 503(1):177-180. PubMed ID: 29885836
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of histone deacetylase activity attenuates renal fibroblast activation and interstitial fibrosis in obstructive nephropathy.
Pang M; Kothapally J; Mao H; Tolbert E; Ponnusamy M; Chin YE; Zhuang S
Am J Physiol Renal Physiol; 2009 Oct; 297(4):F996-F1005. PubMed ID: 19640900
[TBL] [Abstract][Full Text] [Related]
8. Apamin inhibits renal fibrosis via suppressing TGF-β1 and STAT3 signaling in vivo and in vitro.
Gwon MG; An HJ; Gu H; Kim YA; Han SM; Park KK
J Mol Med (Berl); 2021 Sep; 99(9):1265-1277. PubMed ID: 34031696
[TBL] [Abstract][Full Text] [Related]
9. STAT3 Inhibition Partly Abolishes IL-33-Induced Bone Marrow-Derived Monocyte Phenotypic Transition into Fibroblast Precursor and Alleviates Experimental Renal Interstitial Fibrosis.
Zhu F; Bai X; Hong Q; Cui S; Wang X; Xiao F; Li J; Zhang L; Dong Z; Wang Y; Cai G; Chen X
J Immunol; 2019 Nov; 203(10):2644-2654. PubMed ID: 31591147
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of STAT3 activation mediated by toll-like receptor 4 attenuates angiotensin II-induced renal fibrosis and dysfunction.
Xu Z; Zou C; Yu W; Xu S; Huang L; Khan Z; Wang J; Liang G; Wang Y
Br J Pharmacol; 2019 Jul; 176(14):2627-2641. PubMed ID: 30958891
[TBL] [Abstract][Full Text] [Related]
11. JAK3/STAT6 Stimulates Bone Marrow-Derived Fibroblast Activation in Renal Fibrosis.
Yan J; Zhang Z; Yang J; Mitch WE; Wang Y
J Am Soc Nephrol; 2015 Dec; 26(12):3060-71. PubMed ID: 26032813
[TBL] [Abstract][Full Text] [Related]
12. Wnt-dependent beta-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis.
Surendran K; Schiavi S; Hruska KA
J Am Soc Nephrol; 2005 Aug; 16(8):2373-84. PubMed ID: 15944336
[TBL] [Abstract][Full Text] [Related]
13. Macrophages, myofibroblasts, and extracellular matrix accumulation in interstitial fibrosis of chronic progressive nephropathy in aged rats.
Nakatsuji S; Yamate J; Sakuma S
Vet Pathol; 1998 Sep; 35(5):352-60. PubMed ID: 9754540
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic inhibiting STAT3 delays the progression of kidney fibrosis in hyperuricemia-induced chronic kidney disease.
Pan J; Shi M; Guo F; Ma L; Fu P
Life Sci; 2021 Nov; 285():119946. PubMed ID: 34516993
[TBL] [Abstract][Full Text] [Related]
15. Leukemia inhibitory factor attenuates renal fibrosis through Stat3-miR-29c.
Yu Y; Wang Y; Niu Y; Fu L; Chin YE; Yu C
Am J Physiol Renal Physiol; 2015 Oct; 309(7):F595-603. PubMed ID: 26155847
[TBL] [Abstract][Full Text] [Related]
16. Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy.
Yang J; Liu Y
Am J Physiol Renal Physiol; 2003 Feb; 284(2):F349-57. PubMed ID: 12529273
[TBL] [Abstract][Full Text] [Related]
17. Activation of Sirtuin-1 Promotes Renal Fibroblast Activation and Aggravates Renal Fibrogenesis.
Ponnusamy M; Zhuang MA; Zhou X; Tolbert E; Bayliss G; Zhao TC; Zhuang S
J Pharmacol Exp Ther; 2015 Aug; 354(2):142-51. PubMed ID: 26022003
[TBL] [Abstract][Full Text] [Related]
18. Critical roles of SMYD2 lysine methyltransferase in mediating renal fibroblast activation and kidney fibrosis.
Liu L; Liu F; Guan Y; Zou J; Zhang C; Xiong C; Zhao TC; Bayliss G; Li X; Zhuang S
FASEB J; 2021 Jul; 35(7):e21715. PubMed ID: 34143514
[TBL] [Abstract][Full Text] [Related]
19. PAI-1 deficiency attenuates the fibrogenic response to ureteral obstruction.
Oda T; Jung YO; Kim HS; Cai X; López-Guisa JM; Ikeda Y; Eddy AA
Kidney Int; 2001 Aug; 60(2):587-96. PubMed ID: 11473641
[TBL] [Abstract][Full Text] [Related]
20. Protein arginine methyltransferase 1 mediates renal fibroblast activation and fibrogenesis through activation of Smad3 signaling.
Zhu Y; Yu C; Zhuang S
Am J Physiol Renal Physiol; 2020 Feb; 318(2):F375-F387. PubMed ID: 31813251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
